23andMe stock falls after company says CFO to depart


Shares of 23andMe Holding Co. ME, -20.33% were falling more than 7% in premarket trading Friday after the DNA-testing company disclosed that Chief Financial Officer Stevem Schoch was resigning from the company. He will stop being 23andMe’s “principal financial officer and principal accounting officer” as of Sept. 1, though he intends to stay with the company through Sept. 30 to help with the transition. The resignation “is not the result of any dispute or disagreement with the Company, including any matters relating to the Company’s accounting practices or financial reporting,” 23andMe said in a filing with the Securities and Exchange Commission. Joseph Selsavage will serve as 23andMe’s interim chief financial and accounting officer. He is currently the chief financial officer of Lemonaid Health, which 23andMe acquired in November.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleThe Escape Home: This is the affordable Caribbean paradise you need to visit
Next articleOnline retailer Wayfair to lay off 5% of employees


Please enter your comment!
Please enter your name here